Algert Global’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-445,811
Closed -$4.35M 1286
2025
Q3
$4.35M Buy
445,811
+397,661
+826% +$3.06M 0.07% 447
2025
Q2
$292K Buy
+48,150
New +$361K 0.01% 1031
2024
Q4
Sell
-72,961
Closed -$1.22M 1294
2024
Q3
$1.22M Sell
72,961
-4,230
-5% -$90.9K 0.03% 709
2024
Q2
$1.59M Buy
77,191
+28,841
+60% +$624K 0.05% 539
2024
Q1
$1.2M Sell
48,350
-908
-2% -$27K 0.05% 569
2023
Q4
$1.79M Buy
49,258
+21,258
+76% +$818K 0.07% 448
2023
Q3
$1.35M Buy
+28,000
New +$1.66M 0.06% 495
2023
Q1
Sell
-19,203
Closed -$1.16M 1274
2022
Q4
$1.16M Buy
19,203
+10,533
+121% +$617K 0.06% 516
2022
Q3
$526K Buy
+8,670
New +$274K 0.03% 785
2022
Q2
Sell
-16,875
Closed -$617K 1342
2022
Q1
$617K Buy
+16,875
New +$608K 0.04% 738

Other funds holding PRTA

Algert Global's PRTA Position: Q4 2025 in Review

Algert Global sold out of Prothena Corp (PRTA) in Q4 2025, closing a stake of 445,811 shares — an estimated $4.35M sold.

Algert Global first reported a position in PRTA in Q1 2022 and held it in 10 quarters. The position peaked at $4.35M in Q3 2025. 181 funds tracked by Wall St. Rank hold PRTA as of Q4 2025.

  • Algert Global reported no remaining Prothena Corp position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 445,811 Prothena Corp shares in Q4 2025, an estimated $4.35M.
  • Algert Global first reported a position in Prothena Corp in Q1 2022 and held it in 10 quarters.
  • Algert Global's Prothena Corp position peaked at $4.35M in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.